Stanley Laman Group, Ltd. Merck & Co., Inc. Transaction History

Stanley Laman Group, Ltd.

  • $652 Million
  • Q4 2024

A detailed history of Stanley Laman Group, Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 3,981 shares of MRK stock, worth $350,527. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,981
Previous 6,024 33.91%
Holding current value
$350,527
Previous $684,000 42.11%
% of portfolio
0.06%
Previous 0.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
SELL
$96.31 - $114.76 $196,761 - $234,454
-2,043 Reduced 33.91%
3,981 $396,000
Q3 2024

Oct 21, 2024
BUY
$111.15 - $128.97 $108,815 - $126,261
979 Added 19.41%
6,024 $684,000
Q2 2024

Jul 18, 2024
BUY
$123.8 - $132.96 $169,234 - $181,756
1,367 Added 37.17%
5,045 $624,000
Q4 2023

Feb 02, 2024
BUY
$100.18 - $109.02 $21,939 - $23,875
219 Added 6.33%
3,678 $400,000
Q3 2023

Oct 16, 2023
BUY
$102.95 - $114.33 $308 - $342
3 Added 0.09%
3,459 $356,000
Q2 2023

Aug 08, 2023
BUY
$108.61 - $118.38 $760 - $828
7 Added 0.2%
3,456 $398,000
Q1 2023

Apr 17, 2023
BUY
$102.94 - $114.86 $355,040 - $396,152
3,449 New
3,449 $366,000
Q1 2021

May 05, 2021
SELL
$68.86 - $81.11 $1.41 Million - $1.67 Million
-20,540 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$71.77 - $79.65 $308,108 - $341,937
4,293 Added 26.42%
20,540 $1.68 Million
Q3 2020

Oct 20, 2020
SELL
$73.18 - $82.95 $112,989 - $128,074
-1,544 Reduced 8.68%
16,247 $1.35 Million
Q2 2020

Jul 20, 2020
BUY
$70.42 - $80.13 $50,631 - $57,613
719 Added 4.21%
17,791 $1.38 Million
Q1 2020

May 12, 2020
BUY
$63.36 - $87.82 $160,554 - $222,535
2,534 Added 17.43%
17,072 $1.31 Million
Q4 2019

Feb 04, 2020
SELL
$77.58 - $87.54 $50,116 - $56,550
-646 Reduced 4.25%
14,538 $1.32 Million
Q3 2019

Nov 08, 2019
SELL
$76.08 - $82.93 $100,273 - $109,301
-1,318 Reduced 7.99%
15,184 $1.28 Million
Q2 2019

Aug 01, 2019
BUY
$69.84 - $81.59 $66,976 - $78,244
959 Added 6.17%
16,502 $1.38 Million
Q1 2019

May 10, 2019
BUY
$69.58 - $79.36 $35,207 - $40,156
506 Added 3.37%
15,543 $1.29 Million
Q4 2018

Feb 07, 2019
SELL
$65.24 - $75.71 $31,902 - $37,022
-489 Reduced 3.15%
15,037 $1.15 Million
Q3 2018

Oct 30, 2018
SELL
$57.69 - $67.84 $440,982 - $518,568
-7,644 Reduced 32.99%
15,526 $1.1 Million
Q2 2018

Aug 09, 2018
BUY
$50.83 - $59.72 $159,402 - $187,281
3,136 Added 15.65%
23,170 $1.41 Million
Q1 2018

May 01, 2018
BUY
$50.96 - $59.23 $7,593 - $8,825
149 Added 0.75%
20,034 $1.09 Million
Q4 2017

Feb 09, 2018
BUY
$51.62 - $61.64 $570,813 - $681,615
11,058 Added 125.27%
19,885 $1.12 Million
Q3 2017

Nov 13, 2017
BUY
$58.67 - $63.13 $517,880 - $557,248
8,827
8,827 $565,000

Others Institutions Holding MRK

# of Institutions
3,855
Shares Held
1.89B
Call Options Held
15.5M
Put Options Held
13.6M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $223B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Stanley Laman Group, Ltd. Portfolio

Follow Stanley Laman Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email